Canada· CA-DIN-02130955
TYPHIM VI
A typhus, gereinigtes polysaccharid-antigen product containing salmonella typhi ty2 vi capsular polysaccharide, registered in Canada by SANOFI PASTEUR LIMITED. The same ATC class is registered in 9 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Typhus, gereinigtes polysaccharid-antigen is registered in 9 of 19 countries.
Countries holding a registration under ATC J07AP03 (typhus, gereinigtes polysaccharid-antigen), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 5 of them publish a price we can compare per daily dose
Typhus, gereinigtes polysaccharid-antigen · ATC J07AP03
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- SALMONELLA TYPHI TY2 VI CAPSULAR POLYSACCHARIDE
- Manufacturer
- SANOFI PASTEUR LIMITED
- Country
- Canada (CA)
- ATC code
- J07AP03
- ATC class
- Typhus, gereinigtes Polysaccharid-Antigen
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07AP03
Typhus, gereinigtes polysaccharid-antigen, as other registers publish it.
- FinlandTypherixGlaxoSmithKline Biologicals SA
- BelgiumTypherix 25 µg/0,5 mlGlaxoSmithKline Biologicals
- FinlandTyphim ViSanofi Winthrop Industrie
- DenmarkTyphim ViOrifarm A/S
- DenmarkTyphim ViParanova Danmark ApS
- IcelandTyphim ViSanofi Winthrop Industrie
- IcelandTyphim ViSanofi Winthrop Industrie
- NorwayTyphim ViSanofi Winthrop Industrie
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fae42a69-a6fe-40ce-b359-079df7a8c9ca GET /v1/drugs/fae42a69-a6fe-40ce-b359-079df7a8c9ca?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02130955",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAMUSCULAR"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "J07AP03",
"schedule": [
"Schedule D"
],
"drug_code": "20287",
"strengths": [
"25 MCG"
],
"ahfs_class": null,
"substances": [
"SALMONELLA TYPHI TY2 VI CAPSULAR POLYSACCHARIDE"
],
"product_categorization": null
}See everything about typhus, gereinigtes polysaccharid-antigen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.